To The Moon

💰 Last week, U.S. stocks have staged a strong rebound, and economic data this week may cause fluctuations.💹 $Progressive(PGR)$/$Allstate(ALL)$/$Chubb(CB)$: The insurance sector has regained favor.📣 Stay tuned, supercharge purchasing power through CashBoost!Last week, F03 surged over 13%. Congratulations to our readers.| Insurance stocks surgeIn May 2025, the U.S. stock market welcomed the IPOs of $Aspen Insurance Holdings Ltd.(AHL)$ and $American Integrity Insurance Group, Inc.(AII)$ , drawing attention to the insurance sector.After facing macroeconomic uncertainties and interest rate

The 2025 list of Singapore’s Best Employers is out, and once again, Apple takes the top spot. After overtaking Google in 2024, it has managed to hold its lead for a second year — no small feat in such a competitive landscape. In contrast, Google, which led the list in 2023 with an impressive score of 9.13, has slipped down to 8th place. What’s particularly interesting is how local companies are making strong moves. The usual banking giants — DBS, OCBC, and UOB — continue to be pillars of consistency, but other names stood out this year. Singapore Airlines (SIA) and Koufu Group made impressive progress this year. It's great to see a broader mix of industries being recognised for treating their employees well. These rankings are based on extensive surveys from employees, which makes them wor

The Gold Miners ETF (GDX) is showing promising signs for investors as it approaches a critical support zone. Since the low on December 30, 2024, GDX has been tracing a five-wave impulse pattern. This is a hallmark of bullish momentum in Elliott Wave analysis. The first wave (wave (1)) peaked at $42.66, followed by a pullback to $38.58 in wave (2). From there, GDX surged in wave (3) to $53.25, as seen on the one-hour chart below. Currently, the ETF is in a corrective wave (4), unfolding as a zigzag pattern, which is nearing completion. The zigzag’s wave A dropped to $46.73, with its internal structure showing five sub-waves. Wave ((i)) at $50.95, a rally to $52.99 in wave ((ii)), a decline to $47.77 in wave ((iii)), a bounce to $50.09 in wave ((iv)), and a final dip to $46.73 in wave ((v)).

On Friday, May 16th, the markets wrapped up a stellar week with a burst of energy. Economic data rolled in, and U.S. Treasury yields kept sliding, giving stocks a nice tailwind. By the closing bell, stock indices were all in the green, putting a perfect bow on a robust week.  The S&P 500? Up a solid 5.3% for the week. The Nasdaq? Even better, soaring 6.87%. What fueled this? Global trade tensions eased, sparking a rush of risk appetite. Plus, corporate earnings came in stronger than expected, lifting spirits across the board. Technically, the S&P 500 was a beast, holding firm above its 5-day moving average and relentlessly pushing through resistance. Everyone trying to call the top of this short-squeeze rally? They’ve thrown in the towel. A true short squeeze doesn’t care abou

$UnitedHealth(UNH)$ 🚨📉🔥 Should You Buy the Dip? $UNH Is the Ultimate High-Conviction Test Case 🔥📉🚨 In a market drowning in volatility and regulatory headlines, the sharpest insights don’t come from talking heads, they come from the cold, hard data of insider moves. On May 15, 2025, Timothy P. Flynn, a director at UnitedHealth Group ($UNH), dropped nearly $500,000 of his own capital to scoop up 1,533 shares at $320.80 each via a trust. This wasn’t a PR stunt or a casual dip of the toe, it was a bold, deliberate bet, executed as the stock weathered a storm of fear and tested critical support levels. The question that slices through the noise is this: Why would an insider, with intimate knowledge of the company’s inner workings, pour personal wealth i

The latest 13F filings have dropped, and the moves from Berkshire Hathaway and Michael Burry are turning heads. Warren Buffett’s trimming his bank exposure like it’s out of fashion, while Burry, the oracle of market meltdowns, has slashed his portfolio to a single stock. What’s behind these bold plays? Let’s break it down and uncover the insights. What’s a 13F Filing? These quarterly SEC reports are a goldmine, showing what institutional giants managing over $100 million are buying and selling. Today, we’re spotlighting Berkshire Hathaway and Michael Burry—two names that move markets. Berkshire’s Portfolio Shake-Up Buffett’s been busy with the pruning shears in Q1 2025. Here’s what Berkshire’s up to: Full Exits: Citigroup: Out completely. Nu Holdings: The Brazilian digital bank is gone too

UnitedHealth Group ( $UnitedHealth(UNH)$ ) is reeling from a perfect storm of bad news. A criminal probe into alleged Medicare fraud has sent its stock tumbling an additional 16%, compounding an 18% drop triggered by CEO Andrew Witty’s sudden exit and the scrapping of its 2025 earnings outlook. With President Trump’s new drug pricing executive order adding pressure to the healthcare sector, UNH’s stock is down 38% year-to-date, trading near $311. Is this a golden opportunity to buy a beaten-down giant, or a warning to stay away? And will biotech stocks take a bigger hit from Trump’s aggressive pricing push? Let’s dive into the chaos and explore what’s next. 🔍 What’s Happening? Medicare Fraud Probe: The U.S. Department of Justice is investigating UN

$UnitedHealth(UNH)$  UnitedHealth Group (NYSE: UNH), the healthcare behemoth, has seen its stock price plummet by a staggering 50% year-to-date. For a company historically known for its stability and growth, this sharp decline has raised eyebrows and opened up a major debate among investors: Is this the perfect buying opportunity, or are we witnessing the start of a prolonged downturn? What Happened to UNH? To understand the dramatic drop, we need to look at the broader context. UnitedHealth has been grappling with multiple headwinds this year: Regulatory Pressures: The U.S. government’s increased scrutiny on healthcare pricing, Medicare, and insurance practices has cast a shadow over UnitedHealth's long-term revenue

$Renaissance IPO ETF(IPO)$ Hong Kong’s IPO market is sizzling in 2025, with nearly half of new listings delivering eye-popping gains on their debut. Auntea Jenny skyrocketed over 50% on its first trading day, while Mixue soared 43%, turning heads and filling wallets. These blockbuster performances are part of a broader trend that’s got investors buzzing with excitement. But is this boom a golden ticket to profits, or a bubble waiting to burst? Let’s unpack the drivers, risks, and whether you should jump into this red-hot market. 🔍 What’s Happening? Hong Kong’s IPO scene is on fire. According to KPMG, Q1 2025 saw 15 IPOs raising HK$17.7 billion—a 277% surge from Q1 2024’s HK$4.7 billion. Deal sizes ballooned by 195%, with six IPOs exceeding HK$1 bil